Transgenic mice models of AD have shown a significant disparity in O-GlcNAcylation and phosphorylation with tau protein being hyperphosphorylated at specific serine residues followed by a drop in O-GlcNAcylation levels (Bourré et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.